CN118556865A - Medium-chain triglyceride composition, sugar-free embedding preparation method and application thereof - Google Patents
Medium-chain triglyceride composition, sugar-free embedding preparation method and application thereof Download PDFInfo
- Publication number
- CN118556865A CN118556865A CN202411060502.3A CN202411060502A CN118556865A CN 118556865 A CN118556865 A CN 118556865A CN 202411060502 A CN202411060502 A CN 202411060502A CN 118556865 A CN118556865 A CN 118556865A
- Authority
- CN
- China
- Prior art keywords
- chain triglyceride
- medium chain
- parts
- triglyceride composition
- microcapsule powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title claims abstract description 98
- 239000000203 mixture Substances 0.000 title claims abstract description 83
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 93
- 239000003094 microcapsule Substances 0.000 claims abstract description 63
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 33
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 29
- 235000008397 ginger Nutrition 0.000 claims abstract description 29
- 239000000463 material Substances 0.000 claims abstract description 29
- 235000020744 piper nigrum extract Nutrition 0.000 claims abstract description 29
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 28
- 229920001353 Dextrin Polymers 0.000 claims abstract description 27
- 239000004375 Dextrin Substances 0.000 claims abstract description 27
- 235000019425 dextrin Nutrition 0.000 claims abstract description 27
- 240000006499 Flammulina velutipes Species 0.000 claims abstract description 22
- 235000016640 Flammulina velutipes Nutrition 0.000 claims abstract description 22
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 19
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 19
- 239000001259 polydextrose Substances 0.000 claims abstract description 19
- 229940035035 polydextrose Drugs 0.000 claims abstract description 19
- 108010084695 Pea Proteins Proteins 0.000 claims abstract description 18
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- 235000019702 pea protein Nutrition 0.000 claims abstract description 18
- 235000021119 whey protein Nutrition 0.000 claims abstract description 18
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims description 30
- 241000234314 Zingiber Species 0.000 claims description 28
- 229920000858 Cyclodextrin Polymers 0.000 claims description 21
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 18
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 18
- 229920002774 Maltodextrin Polymers 0.000 claims description 12
- 239000005913 Maltodextrin Substances 0.000 claims description 11
- 229940035034 maltodextrin Drugs 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 230000004060 metabolic process Effects 0.000 abstract description 17
- 230000007102 metabolic function Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 244000130270 Fagopyrum tataricum Species 0.000 description 5
- 235000014693 Fagopyrum tataricum Nutrition 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 5
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 5
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 229930003944 flavone Natural products 0.000 description 5
- 150000002212 flavone derivatives Chemical class 0.000 description 5
- 235000011949 flavones Nutrition 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000001694 spray drying Methods 0.000 description 5
- 229940116269 uric acid Drugs 0.000 description 5
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 5
- 230000004580 weight loss Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 229940057917 medium chain triglycerides Drugs 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 241001070941 Castanea Species 0.000 description 2
- 235000014036 Castanea Nutrition 0.000 description 2
- 229920002245 Dextrose equivalent Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 241001474374 Blennius Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 241000274177 Juniperus sabina Species 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- 235000004727 Opuntia ficus indica Nutrition 0.000 description 1
- 240000009297 Opuntia ficus-indica Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a medium chain triglyceride composition, a sugar-free embedding preparation method and application thereof, and relates to the technical field of foods. The medium chain triglyceride composition of the invention comprises the following raw materials in parts by weight: 1-4 parts of medium chain triglyceride microcapsule powder, 0.5-2 parts of flammulina velutipes extract, 0.5-1.8 parts of black pepper extract, 0.5-1.8 parts of ginger microcapsule powder, 0.5-2 parts of citrus fruit powder, 0.1-0.6 part of polydextrose and 1-3.5 parts of embedding material; the weight ratio of pea protein, whey protein and dextrin in the embedding material is 0.5-1.5:1-1.8:2-3; the medium chain triglyceride composition is prepared by a sugar-free embedding method. The medium chain triglyceride composition has the effect of remarkably improving the weight losing and metabolism functions; the formula has strong applicability, and can be applied to the preparation of food with the functions of losing weight and promoting metabolism.
Description
Technical Field
The invention belongs to the technical field of foods, and particularly relates to a medium-chain triglyceride composition, a sugar-free embedding preparation method and application thereof.
Background
Obesity is mainly due to excessive energy intake, which promotes excessive fat synthesis in the body, resulting in excessive fat accumulation in the body. After fat is formed in the body, the fat is accumulated in mature fat cell interstitial mass, so that fat volume is increased, and body weight, body fat content, blood fat and the like are increased. In addition to reducing energy intake or increasing consumption in increments, promoting fat metabolism levels may improve obesity for weight loss purposes. Fat metabolism is the process of digestion, absorption, synthesis and decomposition of fat in a living body under the action of enzymes, and normal physiological function operation can be ensured through fat metabolism.
The Chinese patent CN114515009A discloses a composition with the effects of losing weight and reducing blood fat and application thereof, wherein the composition with the effects of losing weight and reducing blood fat comprises the following components: the acanthopanax extract, the lychee seed extract, the beer yeast and the nuciferine are matched with each other to realize synergistic interaction, so that the fat metabolism of a human body is obviously promoted and balanced, the effects of reducing blood fat, reversing fatty liver and the like are achieved, and meanwhile, the effects of losing weight, relaxing the bowels, expelling toxin and promoting sleep are obvious.
The Chinese patent CN116530683A discloses a food composition for enhancing fat metabolism and a preparation method thereof, wherein the raw materials of the food composition comprise medium chain triglyceride microcapsule powder, green coffee powder, green tea powder, seaweed powder, sea buckthorn powder, medlar powder, stachyose, opuntia ficus-indica, virgin coconut oil microcapsule powder and sugarcane polyphenol; the final composition can enhance fat metabolism.
Medium Chain Triglycerides (MCT) are one of the sources of dietary fat and can be used as a functional food material or food additive for weight loss. At present, the single-component food has poor overall improving capability on fat metabolism, while the compound food has the problems of complex formula and preparation process, poor universality, poor functionality, poor efficacy and the like. The plant active ingredient with the effects of losing weight and promoting fat metabolism is easy to oxidize, and even has reduced active function in the storage process, so that the fat metabolism and other weight losing effects are reduced. Therefore, there is a need to provide an embedding technique for embedding medium chain triglycerides and plant active ingredients to improve the stability of the composition, and further synergistically improve the efficacy of losing weight and fat metabolism.
Chinese patent No. CN111150086a discloses an embedding wall material and embedding technique and application of microcapsule tartary buckwheat flavone, the embedding wall material includes: resistant dextrins and dextrins, the dextrins including maltodextrins and cyclodextrins; the embedding technology of the microcapsule tartary buckwheat flavone comprises the following steps: crushing tartary buckwheat bran, carrying out ethanol sectional ultrasonic leaching to obtain leaching liquor, concentrating the leaching liquor to obtain a concentrated solution containing flavone, adding the concentrated solution into embedding wall material liquid, mixing, and spray-drying to obtain microcapsule tartary buckwheat flavone. The embedding wall material has good embedding effect, high embedding rate and high drug loading rate, and can better maintain the physiological activity of the tartary buckwheat flavone.
Dextrin wall materials are often used for embedding active substances and aroma substances, but when cyclodextrin or maltodextrin is used as a wall material for preparing a product, physical and chemical characteristics such as solubility, hygroscopicity, stability and the like of the product are often influenced by the types, proportions and Dextrose Equivalent (DE) of the dextrin, so that the cyclodextrin or maltodextrin is limited in use.
In view of this, there is a need for a composition with weight loss and metabolic function that maintains the activity of a combination of medium chain triglycerides and plant active ingredients by selecting an appropriate embedding material to further enhance product stability and weight loss efficacy.
Disclosure of Invention
Aiming at the problems existing in the prior art, the invention provides a medium chain triglyceride composition, a sugar-free embedding preparation method and application thereof, and the composition is treated by a sugar-free embedding process, so that the storage stability is obviously improved; the active ingredients of flammulina velutipes extract, black pepper extract, ginger microcapsule powder, citrus fruit powder and medium chain triglyceride microcapsule powder are compounded, and the effects of the components are synergistic, so that the flammulina velutipes extract, black pepper extract, ginger microcapsule powder, citrus fruit powder and medium chain triglyceride microcapsule powder have remarkable effects of improving metabolism and losing weight.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
First, the invention provides a medium chain triglyceride composition, which comprises the following raw materials in parts by weight: 1-4 parts of medium chain triglyceride microcapsule powder, 0.5-2 parts of flammulina velutipes extract, 0.5-1.8 parts of black pepper extract, 0.5-1.8 parts of ginger microcapsule powder, 0.5-2 parts of citrus fruit powder, 0.1-0.6 part of polydextrose and 1-3.5 parts of embedding material;
the embedding material comprises the following components: pea protein, whey protein and dextrin; the weight ratio of pea protein, whey protein and dextrin is 0.5-1.5:1-1.8:2-3.
Preferably, the medium chain triglyceride composition comprises the following raw materials in parts by weight: 1.5 to 2.2 parts of medium chain triglyceride microcapsule powder, 1 to 1.5 parts of flammulina velutipes extract, 0.8 to 1.5 parts of black pepper extract, 0.8 to 1.5 parts of ginger microcapsule powder, 0.8 to 1.5 parts of citrus fruit powder, 0.2 to 0.5 part of polydextrose and 1.5 to 2.5 parts of embedding material.
Further preferably, the medium chain triglyceride composition comprises the following raw material components in parts by weight: 2 parts of medium chain triglyceride microcapsule powder, 1.5 parts of flammulina velutipes extract, 1 part of black pepper extract, 1 part of ginger microcapsule powder, 1 part of citrus fruit powder, 0.2 part of polydextrose and 2 parts of embedding material.
Preferably, the dextrin is at least one selected from maltodextrin and gamma-cyclodextrin.
Preferably, the weight ratio of pea protein, whey protein and dextrin in the embedding material is 1:1.5:2.5.
Preferably, in the medium chain triglyceride composition, the weight ratio of the medium chain triglyceride microcapsule powder to the flammulina velutipes extract to the black pepper extract to the ginger microcapsule powder to the citrus fruit powder is 1-4:0.5-2:0.5-1.8:0.5-1.8:0.5-2.
Further preferably, in the medium chain triglyceride composition, the weight ratio of the medium chain triglyceride microcapsule powder, the flammulina velutipes extract, the black pepper extract, the ginger microcapsule powder and the citrus fruit powder is 1.5-2.2:1-1.5:0.8-1.5:0.8-1.5:0.8-1.5.
Still further preferably, the weight ratio of medium chain triglyceride microcapsule powder, needle mushroom extract, black pepper extract, ginger microcapsule powder and citrus fruit powder in the medium chain triglyceride composition is 2:1.5:1:1:1.
The invention then provides a process for the preparation of the above medium chain triglyceride composition, in particular a sugar-free embedding process, comprising the steps of:
(1) Mixing dextrin with water, and heating to dissolve to obtain a dextrin mixture;
(2) Mixing dextrin mixture, medium chain triglyceride microcapsule powder, needle mushroom extract, black pepper extract, ginger microcapsule powder, citrus fruit powder and polydextrose, stirring, and performing first embedding to obtain a first embedded product;
(3) Mixing the first embedded product obtained in the step (2) with pea protein and whey protein, stirring and drying to obtain the medium chain triglyceride composition.
Preferably, in the step (1), the weight ratio of the dextrin to the water is 1:60-100.
Further preferably, the weight ratio of dextrin to water is 1:80.
Preferably, in the step (1), the heating and dissolving are specifically: stirring at 85-100deg.C and 100-200rpm until dextrin is dissolved.
Further preferably, the heating and dissolving are specifically stirring at 85-95deg.C and 180rpm until the dextrin is dissolved.
Preferably, in step (2), the stirring is: stirring at 100-200rpm for 1-3h.
Further preferably, in step (2), the stirring is: stirring at 180rpm for 2h.
Preferably, in step (3), the stirring is: stirring at 100-200rpm for 0.5-2h.
Further preferably, in step (3), the stirring is: stirring at 180rpm for 1h.
Finally, the invention provides application of the medium chain triglyceride composition in food with weight losing and metabolism promoting functions.
Compared with the prior art, the invention has the following beneficial effects:
1. In the medium chain triglyceride composition, the flammulina velutipes extract can promote fat metabolism; the black pepper extract can improve the permeability of active ingredients, thereby improving the metabolic function; the ginger microcapsule powder can inhibit fat cell factor; the flammulina velutipes extract, the black pepper extract and the ginger microcapsule powder are compounded with the medium-chain triglyceride microcapsule powder and the citrus fruit powder, so that the effects are synergistic, and the effects of reducing weight and metabolism are remarkably improved.
2. The medium chain triglyceride composition is prepared by a sugar-free embedding process, and pea protein, whey protein and dextrin are used for embedding, so that the stability of the obtained medium chain triglyceride composition is obviously improved, and the activity of active substance components can be protected, so that the metabolic function is further improved.
3. The medium chain triglyceride composition has strong applicability, and can be applied to the preparation of various foods.
Detailed Description
The following non-limiting examples will enable those of ordinary skill in the art to more fully understand the invention and are not intended to limit the invention in any way. The following is merely exemplary of the scope of the invention as it is claimed and many variations and modifications of the invention will be apparent to those skilled in the art in light of the disclosure, which should be considered as falling within the scope of the invention as claimed.
Where numerical ranges are provided in the examples, it is understood that unless otherwise stated herein, both endpoints of each numerical range and any number between the two endpoints are significant both in the numerical range. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
The invention is further illustrated by means of the following specific examples. The various chemical reagents used in the examples of the present invention were obtained by conventional commercial means unless otherwise specified.
In the following examples, medium chain triglyceride microcapsule powder was purchased from Dalian medical norbovines Co., ltd., INNOBIO medium chain triglyceride microcapsule powder; needle mushroom extracts were purchased from biotechnology company in western security; black pepper extract was purchased from sabina (south kyo) biotechnology limited; ginger microcapsule powder was purchased from Shaanxi Jiyuan Biotechnology Co., ltd; citrus fruit powder was purchased from the trade company, chinese, guangzhou; pea protein was purchased from caldick; whey protein was purchased from Shanghai Purocarkini International trade Limited; maltodextrin was purchased from Luo Gaite; gamma-cyclodextrin was purchased from Jiangsu Fengyuan biotechnology limited. The components have no obvious influence on the effect of products of different factories.
Example 1 to example 5
Examples 1-5 each show a medium chain triglyceride composition with the raw material composition in parts by weight as shown in Table 1.
TABLE 1
The medium chain triglyceride composition of examples 1-5, which was prepared by a sugar-free embedding method:
(1) Mixing gamma-cyclodextrin with 80 weight times of water, and stirring at 90 ℃ and 180rpm until the gamma-cyclodextrin is dissolved to obtain a gamma-cyclodextrin mixture;
(2) Mixing the gamma-cyclodextrin mixture obtained in the step (1) with medium chain triglyceride microcapsule powder, flammulina velutipes extract, black pepper extract, ginger microcapsule powder, citrus fruit powder and polydextrose, and magnetically stirring at 180rpm for 2 hours to perform first embedding to obtain a first embedded product;
(3) Mixing the first embedded product obtained in the step (2) with pea protein and whey protein, magnetically stirring at 180rpm for 1h, and spray-drying to obtain the medium chain triglyceride composition.
Example 6
The medium chain triglyceride composition is prepared from the following raw material components in parts by weight: 2 parts of medium chain triglyceride microcapsule powder, 1 part of flammulina velutipes extract, 1 part of black pepper extract, 1 part of ginger microcapsule powder, 1 part of citrus fruit powder, 0.5 part of polydextrose and 2 parts of embedding material;
the embedding material comprises the components of pea protein, whey protein and maltodextrin, wherein the weight ratio of the pea protein to the whey protein to the maltodextrin is 1:1.5:2.5.
The preparation method of the medium chain triglyceride composition of example 6 is:
(1) Mixing maltodextrin with 80 weight times of water, and stirring at 90 ℃ and 180rpm until the maltodextrin is dissolved to obtain a maltodextrin mixture;
(2) Mixing the maltodextrin mixture obtained in the step (1) with medium chain triglyceride microcapsule powder, flammulina velutipes extract, black pepper extract, ginger microcapsule powder, citrus fruit powder and polydextrose, and magnetically stirring at 180rpm for 2 hours, and performing first embedding to obtain a first embedded product;
(3) Mixing the first embedded product obtained in the step (2) with pea protein and whey protein, magnetically stirring at 180rpm for 1h, and spray-drying to obtain the medium chain triglyceride composition.
Comparative example 1
Unlike example 1, the medium chain triglyceride composition does not contain the black pepper extract, and the rest is the same as example 1. The method comprises the following steps:
The medium chain triglyceride composition is prepared from the following raw material components in parts by weight: 2 parts of medium chain triglyceride microcapsule powder, 1.5 parts of flammulina velutipes extract, 1 part of ginger microcapsule powder, 1 part of citrus fruit powder, 0.2 part of polydextrose and 2 parts of embedding material.
Comparative example 2
Unlike example 1, the medium chain triglyceride composition was free of flammulina velutipes extract, ginger micro-capsule powder and citrus fruit powder, and the rest was the same as in example 1. The method comprises the following steps:
The medium chain triglyceride composition is prepared from the following raw material components in parts by weight: 2 parts of medium chain triglyceride microcapsule powder, 1 part of black pepper extract, 0.2 part of polydextrose and 2 parts of embedding material.
Comparative example 3
Unlike example 1, needle mushroom extract was replaced with chestnut skin extract, and the rest was the same as example 1. The method comprises the following steps:
The medium chain triglyceride composition is prepared from the following raw material components in parts by weight: 2 parts of medium chain triglyceride microcapsule powder, 1.5 parts of chestnut skin extract, 1 part of black pepper extract, 1 part of ginger microcapsule powder, 1 part of citrus fruit powder, 0.2 part of polydextrose and 2 parts of embedding material.
Example 4
Unlike example 1, the medium chain triglyceride composition comprises the following components in parts by weight:
The medium chain triglyceride composition is prepared from the following raw material components in parts by weight: 2 parts of medium chain triglyceride microcapsule powder, 1.5 parts of flammulina velutipes extract, 1 part of black pepper extract, 1 part of ginger microcapsule powder, 1 part of citrus fruit powder, 0.1 part of polydextrose and 4.5 parts of embedding material.
The remainder was the same as in example 1.
Comparative example 5
Unlike example 1, the embedding material was free of pea proteins and whey proteins, and the whole of pea proteins and whey proteins were replaced with gamma-cyclodextrin. The rest is the same as in example 1, specifically:
The medium chain triglyceride composition is prepared from the following raw material components in parts by weight: 2 parts of medium chain triglyceride microcapsule powder, 1.5 parts of flammulina velutipes extract, 1 part of black pepper extract, 1 part of ginger microcapsule powder, 1 part of citrus fruit powder, 0.2 part of polydextrose and 2 parts of embedding material; the embedding material is a single component of gamma-cyclodextrin.
The medium chain triglyceride composition of this comparative example was prepared by a sugar-free embedding method:
(1) Mixing 1 part of gamma-cyclodextrin with 80 weight times of water, and stirring at 90 ℃ and 180rpm until the gamma-cyclodextrin is dissolved to obtain a gamma-cyclodextrin mixture;
(2) Mixing the gamma-cyclodextrin mixture obtained in the step (1) with medium chain triglyceride microcapsule powder, flammulina velutipes extract, black pepper extract, ginger microcapsule powder, citrus fruit powder and polydextrose, and magnetically stirring at 180rpm for 2 hours to perform first embedding to obtain a first embedded product;
(3) Mixing the first embedding product obtained in the step (2) with 1 part of gamma-cyclodextrin, magnetically stirring at 180rpm for 1h, and spray-drying to obtain the medium chain triglyceride composition.
Comparative example 6
Unlike example 1, the preparation method of the medium chain triglyceride composition was different, and the preparation method of the comparative example was not subjected to two embedding treatments, specifically, the steps were:
(1) Mixing gamma-cyclodextrin with 80 weight times of water, and stirring at 90 ℃ and 180rpm until the gamma-cyclodextrin is dissolved to obtain a gamma-cyclodextrin mixture;
(2) Mixing the gamma-cyclodextrin mixture obtained in the step (1) with medium chain triglyceride microcapsule powder, flammulina velutipes extract, black pepper extract, ginger microcapsule powder, citrus fruit powder, polydextrose, pea protein and whey protein, magnetically stirring at 180rpm for 3 hours, and spray-drying to obtain the medium chain triglyceride composition.
Test 1 stability test
The medium chain triglyceride compositions of examples 1 to 6, comparative example 2 and comparative examples 4 to 6 were taken and tested for their inclusion rate. The stability of the medium chain triglyceride composition was then evaluated by exposing the medium chain triglyceride composition to conditions of 40℃and 75% relative humidity and sampling on day 0 and day 20, respectively, to evaluate the properties of the medium chain triglyceride composition.
The embedding rate and the detection result are shown in Table 2.
TABLE 2
As can be seen from table 2, the medium chain triglyceride compositions of the present invention are stable under accelerated storage conditions. The embedding method of the invention improves the embedding rate and the stability of the medium chain triglyceride composition.
Experiment 2 metabolism and weight loss efficacy experiment
SPF-grade KM male mice, weighing about 20g (initial body weight), were fed ad libitum, and were fed adaptively for 1 week. The random groups were divided into normal group, model group, examples 1 to 5 group, comparative examples 1 to 3 group, comparative example 5 group, 6 each. In addition to the normal group, the other groups were fed daily with high-fat diet and the normal group was fed daily with normal diet. Continuous feeding for 8 weeks, resulting in hyperlipidemia and obesity models.
Subsequently, the groups of examples 1 to 5, comparative examples 1 to 3, and comparative example 5 were fed with the corresponding medium chain triglyceride composition 0.8 g/kg/day each day, and the normal group and the model group were fed with an equal amount of physiological saline. After 2 weeks of continuous feeding, other groups of mice were intraperitoneally injected with hypoxanthine (600 mg/kg) to model high uric acid, and after 1h, each group of mice was injected with 3% chloral hydrate. Body weight (final body weight) was recorded.
Then, the eyeballs were collected to take blood, and the Total Cholesterol (TC), triglyceride (TG) and uric acid content in the serum were measured.
Total Cholesterol (TC) and Triglyceride (TG) content determination in serum: standing for 1h at room temperature after blood collection, centrifuging, taking serum, and measuring TC and TG contents according to the operation instructions of the kit. The uric acid content in serum is measured by using a veterinary full-automatic biochemical analyzer (BS-240 VET, shenzhen Michael).
The weight change of each group of mice is shown in Table 3.
The TC, TG and uric acid contents in serum are shown in Table 4.
TABLE 3 Table 3
As can be seen from Table 3, the weight of the mice in the model group was significantly increased, and the model of hyperlipidemia and obesity was successful. Normal mice gradually increase in body weight due to natural growth; the weight of a mouse fed with the medium chain triglyceride composition is effectively controlled, and the weight losing effect is remarkable.
TABLE 4 Table 4
In Table 4, #P＜0.05,## P < 0.01 for each experimental group compared to the model group; comparative example set &P＜0.05,&& P < 0.01 compared to example 1 set.
From the results of table 4, it can be seen that the medium chain triglyceride composition of the present invention can reduce blood lipid and uric acid levels, and remarkably improve metabolic functions in mice with hyperlipidemia model. Therefore, the medium chain triglyceride composition of the invention has remarkable effects of improving metabolism and inhibiting obesity.
Finally, it should be noted that the above description is only for illustrating the technical solution of the present invention, and not for limiting the scope of the present invention, and that the simple modification and equivalent substitution of the technical solution of the present invention can be made by those skilled in the art without departing from the spirit and scope of the technical solution of the present invention.
Claims (10)
1. The medium chain triglyceride composition is characterized by comprising the following raw material components in parts by weight: 1-4 parts of medium chain triglyceride microcapsule powder, 0.5-2 parts of flammulina velutipes extract, 0.5-1.8 parts of black pepper extract, 0.5-1.8 parts of ginger microcapsule powder, 0.5-2 parts of citrus fruit powder, 0.1-0.6 part of polydextrose and 1-3.5 parts of embedding material;
the embedding material comprises the following components: pea protein, whey protein and dextrin; the weight ratio of pea protein, whey protein and dextrin is 0.5-1.5:1-1.8:2-3.
2. The medium chain triglyceride composition according to claim 1, wherein the raw material components comprise, in parts by weight: 1.5 to 2.2 parts of medium chain triglyceride microcapsule powder, 1 to 1.5 parts of flammulina velutipes extract, 0.8 to 1.5 parts of black pepper extract, 0.8 to 1.5 parts of ginger microcapsule powder, 0.8 to 1.5 parts of citrus fruit powder, 0.2 to 0.5 part of polydextrose and 1.5 to 2.5 parts of embedding material.
3. The medium chain triglyceride composition according to claim 2, wherein the raw material components comprise, in parts by weight: 2 parts of medium chain triglyceride microcapsule powder, 1.5 parts of flammulina velutipes extract, 1 part of black pepper extract, 1 part of ginger microcapsule powder, 1 part of citrus fruit powder, 0.2 part of polydextrose and 2 parts of embedding material.
4. A medium chain triglyceride composition according to any one of claims 1-3, wherein the dextrin is selected from at least one of maltodextrin, gamma cyclodextrin.
5. A medium chain triglyceride composition according to any one of claims 1-3, wherein the weight ratio of pea protein, whey protein and dextrin in the embedding material is 1:1.5:2.5.
6. The medium chain triglyceride composition according to claim 1, wherein the weight ratio of medium chain triglyceride microcapsule powder, needle mushroom extract, black pepper extract, ginger microcapsule powder and citrus fruit powder is 1.5-2.2:1-1.5:0.8-1.5:0.8-1.5:0.8-1.5.
7. The medium chain triglyceride composition according to claim 6, wherein the weight ratio of medium chain triglyceride microcapsule powder, needle mushroom extract, black pepper extract, ginger microcapsule powder and citrus fruit powder is 2:1.5:1:1:1.
8. A process for the preparation of a medium chain triglyceride composition according to any one of claims 1-7, which is a sugarless embedding process comprising the steps of:
(1) Mixing dextrin with water, and heating to dissolve to obtain a dextrin mixture;
(2) Mixing dextrin mixture, medium chain triglyceride microcapsule powder, needle mushroom extract, black pepper extract, ginger microcapsule powder, citrus fruit powder and polydextrose, stirring, and performing first embedding to obtain a first embedded product;
(3) Mixing the first embedded product obtained in the step (2) with pea protein and whey protein, stirring and drying to obtain the medium chain triglyceride composition.
9. The method according to claim 8, wherein,
In the step (1), the weight ratio of the dextrin to the water is 1:60-100;
In the step (1), the heating and dissolving specifically comprises the following steps: stirring at 85-100deg.C at 100-200rpm until dextrin is dissolved;
in the step (2), the stirring is as follows: stirring at 100-200rpm for 1-3h;
in the step (3), the stirring is as follows: stirring at 100-200rpm for 0.5-2h.
10. Use of a medium chain triglyceride composition in a food having a weight-reducing and metabolism-promoting function, characterized in that the medium chain triglyceride composition is a medium chain triglyceride composition according to any one of claims 1 to 7 or a medium chain triglyceride composition produced by the production method according to any one of claims 8 to 9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202411060502.3A CN118556865A (en) | 2024-08-05 | 2024-08-05 | Medium-chain triglyceride composition, sugar-free embedding preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202411060502.3A CN118556865A (en) | 2024-08-05 | 2024-08-05 | Medium-chain triglyceride composition, sugar-free embedding preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118556865A true CN118556865A (en) | 2024-08-30 |
Family
ID=92473534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202411060502.3A Pending CN118556865A (en) | 2024-08-05 | 2024-08-05 | Medium-chain triglyceride composition, sugar-free embedding preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118556865A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111053190A (en) * | 2019-12-26 | 2020-04-24 | 宁波御坊堂生物科技有限公司 | Light-weight food composition for weight-losing meal replacement and preparation method thereof |
| AU2020101855A4 (en) * | 2020-08-17 | 2020-09-24 | Zhejiang Jinhao Culture Media Co., Ltd. | Citrus and flammulina velutipes tabletting candy and preparation method thereof |
| CN114468284A (en) * | 2022-04-02 | 2022-05-13 | 北京中科生仪科技有限公司 | Composition for losing weight and enhancing immunity, meal replacement powder and preparation process |
| CN117958446A (en) * | 2024-03-28 | 2024-05-03 | 北京衡美金叶营养健康科技有限公司 | Weight-reducing and body-fat-reducing composition, preparation method and application thereof |
| WO2024120305A1 (en) * | 2022-12-07 | 2024-06-13 | 广东金骏康生物技术有限公司 | Citrus composition for weight loss, and preparation method therefor and use thereof |
-
2024
- 2024-08-05 CN CN202411060502.3A patent/CN118556865A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111053190A (en) * | 2019-12-26 | 2020-04-24 | 宁波御坊堂生物科技有限公司 | Light-weight food composition for weight-losing meal replacement and preparation method thereof |
| AU2020101855A4 (en) * | 2020-08-17 | 2020-09-24 | Zhejiang Jinhao Culture Media Co., Ltd. | Citrus and flammulina velutipes tabletting candy and preparation method thereof |
| CN114468284A (en) * | 2022-04-02 | 2022-05-13 | 北京中科生仪科技有限公司 | Composition for losing weight and enhancing immunity, meal replacement powder and preparation process |
| WO2024120305A1 (en) * | 2022-12-07 | 2024-06-13 | 广东金骏康生物技术有限公司 | Citrus composition for weight loss, and preparation method therefor and use thereof |
| CN117958446A (en) * | 2024-03-28 | 2024-05-03 | 北京衡美金叶营养健康科技有限公司 | Weight-reducing and body-fat-reducing composition, preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Campos‐Vega et al. | Chemical composition and in vitro polysaccharide fermentation of different beans (Phaseolus vulgaris L.) | |
| CN101516381B (en) | Composition having effect of treating, preventing, or improving diabetes or diabetic complication and drink comprising the same | |
| JP2011530300A (en) | Yeast nutritional food and method for producing the same | |
| CN106359849B (en) | A kind of fermented feed of the microelement containing humic acid chelating and preparation method thereof | |
| JPH03228667A (en) | Antioxidant mineral drink and production thereof | |
| CN105146271B (en) | A kind of production method of banana resistant starch and dietary fiber composition food with weight losing function | |
| CN106262668A (en) | A kind of preparation method of bacon salt | |
| JPH02211863A (en) | Production of green tea extract having growth promoting characteristic of genus bifidobacterium, green tea extract and method for promoting growth | |
| Cai et al. | Functional nutrients and jujube-based processed products in Ziziphus jujuba | |
| CN118556865A (en) | Medium-chain triglyceride composition, sugar-free embedding preparation method and application thereof | |
| CN111264877A (en) | Preparation method of medicinal and edible high-fiber functional food | |
| KR102303125B1 (en) | Method for producing double-coating red ginseng granule with enhanced ginsenoside content and improved preservability | |
| CN106720915A (en) | The processing method of dragon fruit | |
| CN113907231B (en) | Preparation method of mulberry leaf biological beverage and product | |
| CN103540482A (en) | Kosteletzkya virginica dry root tuber wine | |
| CN103815080B (en) | Tartary buckwheat instant tea and preparation method thereof | |
| CN102250724B (en) | Cordyceps and ginkgo yellow wine as well as preparation method and application thereof | |
| CN117137141A (en) | Composition for resisting exercise-induced fatigue and improving hypoxia tolerance and application thereof | |
| JP2007195444A (en) | Diet food and drink | |
| CN114317313B (en) | Application of sour cherry extract in preparation of product for reducing uric acid or inhibiting gout attack | |
| CN108504491A (en) | A kind of preparation method of fruit wine and its fruit wine obtained and wine product | |
| CN108433000B (en) | Sparassis crispa sobering-up beverage and preparation method thereof | |
| CN113303383A (en) | Lithocarpus polystachyus rehd black tea compound beverage and preparation method thereof | |
| CN207567199U (en) | Red wine structure with health care function | |
| Wang et al. | Extraction, purification, structural characteristic, health benefit, and product application of the polysaccharides from bamboo shoot: A review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |